Obesity’s link to diabetes is well documented and it comes as no surprise that bariatric surgery helps. But new research from Duke University and Columbia University finds that the weight loss surgery works in a way that is quite unexpected. Results of a study published in Science Translational Medicine show that bariatric surgery results in […]
Duke University has established a new $20 million biomedical endowment to support a program that has had a knack for launching new medical companies, focusing in particular on medical technology. The new endowment will allow the program to continue at Duke in perpetuity. Duke was one of nine universities chosen by the Coulter Foundation in […]
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
They go head-to-head in just about everything else, but it's likely that the brass at Boston Scientific and Medtronic both have the Blue Devils going all the way in March Madness. Medtronic Inc. (NYSE:MDT) and Boston Scientific Corp. (NYSE:BSX) share a more than healthy rivalry when it comes to stents, pacemakers and other cardiovascular devices, but when it comes to basketball, it's all Duke baby! That's because the Dukies literally infest the front offices and boardrooms of the two medical device giants.
The prescription safety technology developed by North Carolina company Centice drew more than $22 million in investments over seven years, but the resulting product failed to draw many customers. Now Centice is looking to improve its prospects by adapting the technology for other applications.
Medical imaging technology company Bioptigen, based in Research Triangle Park, North Carolina, has received a warning that its hand-held imaging device for the eye is being marketed beyond the scope of its 510(k) clearance.
Duke University's clinical research organization, the Duke Clinical Research Institute, is partnering with education company Kaplan on a new online training program aimed at workers doing clinical trial work overseas.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Duke University Health System has joined forces with LifePoint Hospitals to run a network of community hospitals in North Carolina. Their first is Maria Parham Medical Center in Henderson, North Carolina.
A new Alzheimer's disease biomarker test developed by Durham, North Carolina-based Zinfandel Pharmaceuticals is licensed by Takeda Pharmaceutical Co. in a deal worth up to $87 million.
Would the Food and Drug Administration advisory committee recommend that the labels of two drugs -- dutasteride, made by GlaxoSmithKline and sold as Avodart; and finasteride, a generic made by Merck and sold as Proscar -- be changed to say they can reduce a man's risk of getting prostate cancer? The answer was no, reports the New York Times.
Samuel D. Waksal, the former chief executive of biotechnology company ImClone Systems who spent five years in federal prison for insider trading is mounting an audacious effort at redemption, again in biotechnology, the New York Times reports.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
"Did you watch the opening ceremony of the Beijing Olympics?" Sen. Amy Klobuchar (D-Minnesota) asked the mostly medical tech audience at a recent LifeScience Alley symposium on healthcare. "Did you see the 2,000 synchronized drummers?" I sure did. And like millions of other Americans, I thought: "Oh, crap. We're in trouble."
Highlights of the important and the interesting from the world of healthcare: Return of the public option? Don’t bet on it: Nearly 130 House Democrats are pushing to restore the once-proposed “public option“–essentially a government-run health plan. Fueling the drive is a report from the Congressional Budget Office that said a public option would shave […]
Case Western Reserve University and University Hospitals Case Medical Center have licensed medical imaging technology called optical coherence tomography (OCT) to Bioptigen Inc. in Research Triangle Park, N.C. Bioptigen plans to use the technology to help the early diagnosis of eye diseases.